- Home
- IPW vs BRNS Comparison
IPW vs BRNS Comparison
Compare IPW & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- BRNS
- Stock Information
- Founded
- IPW 2018
- BRNS 2016
- Country
- IPW United States
- BRNS United Kingdom
- Employees
- IPW N/A
- BRNS N/A
- Industry
- IPW Catalog/Specialty Distribution
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- IPW Consumer Discretionary
- BRNS Health Care
- Exchange
- IPW Nasdaq
- BRNS Nasdaq
- Market Cap
- IPW 14.4M
- BRNS 36.0M
- IPO Year
- IPW 2021
- BRNS 2021
- Fundamental
- Price
- IPW $0.70
- BRNS $1.00
- Analyst Decision
- IPW
- BRNS Strong Buy
- Analyst Count
- IPW 0
- BRNS 1
- Target Price
- IPW N/A
- BRNS $3.00
- AVG Volume (30 Days)
- IPW 298.7K
- BRNS 17.8K
- Earning Date
- IPW 05-15-2025
- BRNS 08-07-2025
- Dividend Yield
- IPW N/A
- BRNS N/A
- EPS Growth
- IPW N/A
- BRNS N/A
- EPS
- IPW N/A
- BRNS N/A
- Revenue
- IPW $74,105,251.00
- BRNS $14,969,000.00
- Revenue This Year
- IPW $8.31
- BRNS N/A
- Revenue Next Year
- IPW $77.15
- BRNS N/A
- P/E Ratio
- IPW N/A
- BRNS N/A
- Revenue Growth
- IPW N/A
- BRNS 4381.74
- 52 Week Low
- IPW $0.41
- BRNS $0.64
- 52 Week High
- IPW $2.36
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- IPW 58.09
- BRNS 55.94
- Support Level
- IPW $0.67
- BRNS $0.90
- Resistance Level
- IPW $0.73
- BRNS $1.10
- Average True Range (ATR)
- IPW 0.06
- BRNS 0.06
- MACD
- IPW 0.00
- BRNS 0.01
- Stochastic Oscillator
- IPW 55.92
- BRNS 60.00
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.